Drug companies on toes amid glare on USFDA – Times of India

[ad_1] MUMBAI: A US congressional panel has voiced concern on the ineffective action on quality lapses taken by its national drug regulator Food and Drug Administration (FDA) particularly in manufacturing facilities in India and China. Together, India and China supply approximately 32% of generic drugs, and nearly half of active pharmaceutical ingredients (APIs) to the … Read more

Sweet medicine: Price of drug going off patent to drop 50% – Times of India

[ad_1] MUMBAI: Price of patented drugs will be halved as soon as they lose patent protection or are on the verge of going off patent in India, providing much-needed relief to patients, reports Rupali Mukherjee.The price of the drug losing patent will be slashed by 50%, and after a year, the MRP will change in … Read more